1

HeraMED

HeraMED
Leadership team

Mr. David Groberman (Co-Founder, CEO & Exec. Director)

Mr. Tal Slonim (Co-Founder, COO & Exec. Director)

Ms. Sivan Sadan (Chief Financial Officer)

Products/ Services
Biotechnology, Electronics, Health Care, Information Technology, Software
Number of Employees
0 - 50
Headquarters
Netanya, HaMerkaz, Israel
Established
2011
Traded as
ASX:HMD
Social Media
Overview
Location
Summary
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregnancy monitor platform for the creation and implementation of digital health solutions for maternity care management. It also develops EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.
History

HeraMED was founded in 2013 with the mission to empower couples with modern, effective, and personalized reproductive health care. Our core products include CP Tracker, a ovulation-predicting monitor and fertility tracking service; FamilyAlbum, a fertility health tracker and health journal; and the HeraClinic network, providing couples with access to personalized reproductive healthcare.

Mission
Our mission is to provide world-class fertility monitoring and personalized reproductive health care to improve couples’ reproductive health outcomes.
Vision
Our vision is to enable couples to create their own family through the highest quality fertility data and personalized reproductive health care.
Key Team

Mr. Ariel Laden (VP of Marketing)

Mr. Michael Nenner (Chief Technology Officer)

Dr. Josef Tovbin (Chief Medical Officer)

Henry Jordan (Head of Investor Relations)

Mr. Jonathan Hart B.Com., L.L.B. (Company Sec.)

Recognition and Awards
HeraMED has been recognized for its technological achievements by the National Institutes of Health, the National Science Foundation, and the World Economic Forum.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

HeraMED
Leadership team

Mr. David Groberman (Co-Founder, CEO & Exec. Director)

Mr. Tal Slonim (Co-Founder, COO & Exec. Director)

Ms. Sivan Sadan (Chief Financial Officer)

Products/ Services
Biotechnology, Electronics, Health Care, Information Technology, Software
Number of Employees
0 - 50
Headquarters
Netanya, HaMerkaz, Israel
Established
2011
Traded as
ASX:HMD
Social Media